Favalli E, Biganzoli G, Cincinelli G, Ferrito M, Luconi E, Manara M
Front Med (Lausanne). 2024; 11:1509082.
PMID: 39736976
PMC: 11682903.
DOI: 10.3389/fmed.2024.1509082.
Ramonda R, Lorenzin M, Chimenti M, Atzeni F, Semeraro A, DAngelo S
Arthritis Res Ther. 2024; 26(1):172.
PMID: 39342310
PMC: 11438205.
DOI: 10.1186/s13075-024-03401-x.
Kwon O, Park M
Yonsei Med J. 2023; 64(12):697-704.
PMID: 37992741
PMC: 10681822.
DOI: 10.3349/ymj.2023.0151.
Queiro R, Aurrecoechea E, Castro S, Villa Blanco I, Brandy-Garcia A, Linge R
Front Immunol. 2023; 14:1203372.
PMID: 37533855
PMC: 10391638.
DOI: 10.3389/fimmu.2023.1203372.
Brana I, Pardo E, Burger S, Gonzalez Del Pozo P, Alperi M, Queiro R
J Clin Med. 2023; 12(2).
PMID: 36675395
PMC: 9861177.
DOI: 10.3390/jcm12020467.
The cardiometabolic conditions of psoriatic disease.
Toussirot E, Gallais-Serezal I, Aubin F
Front Immunol. 2022; 13:970371.
PMID: 36159785
PMC: 9492868.
DOI: 10.3389/fimmu.2022.970371.
Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?.
Gialouri C, Evangelatos G, Fragoulis G
Mediterr J Rheumatol. 2022; 33(Suppl 1):150-161.
PMID: 36127928
PMC: 9450184.
DOI: 10.31138/mjr.33.1.150.
A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab.
Venerito V, Lopalco G, Abbruzzese A, Colella S, Morrone M, Tangaro S
Front Immunol. 2022; 13:917939.
PMID: 35833126
PMC: 9271870.
DOI: 10.3389/fimmu.2022.917939.
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning.
Queiro R, Seoane-Mato D, Laiz A, Agirregoikoa E, Montilla C, Park H
Front Med (Lausanne). 2022; 9:891863.
PMID: 35572968
PMC: 9097678.
DOI: 10.3389/fmed.2022.891863.
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies.
Ritchlin C, Mease P, Boehncke W, Tesser J, Schiopu E, Chakravarty S
RMD Open. 2022; 8(1).
PMID: 35296534
PMC: 8928386.
DOI: 10.1136/rmdopen-2022-002195.
Metabolic Syndrome and Its Components in Psoriatic Arthritis.
Aljohani R
Open Access Rheumatol. 2022; 14:7-16.
PMID: 35210876
PMC: 8860394.
DOI: 10.2147/OARRR.S347797.
Association of Gender, Diagnosis, and Obesity With Retention Rate of Secukinumab in Spondyloarthropathies: Results Form a Multicenter Real-World Study.
Garcia-Dorta A, Leon-Suarez P, Pena S, Hernandez-Diaz M, Rodriguez-Lozano C, Gonzalez-Davila E
Front Med (Lausanne). 2022; 8:815881.
PMID: 35096907
PMC: 8792854.
DOI: 10.3389/fmed.2021.815881.
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice.
Patel S, Kumthekar A
Rheumatol Ther. 2021; 9(1):49-71.
PMID: 34797530
PMC: 8814223.
DOI: 10.1007/s40744-021-00397-7.
Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?.
Atzeni F, Gerratana E, Masala I, Bongiovanni S, Sarzi-Puttini P, Rodriguez-Carrio J
Front Med (Lausanne). 2021; 8:735150.
PMID: 34527685
PMC: 8435605.
DOI: 10.3389/fmed.2021.735150.
Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study.
Alonso S, Villa I, Fernandez S, Martin J, Charca L, Pino M
Front Med (Lausanne). 2021; 8:679009.
PMID: 34124110
PMC: 8187784.
DOI: 10.3389/fmed.2021.679009.
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review.
Karmacharya P, Ogdie A, Eder L
Ther Adv Musculoskelet Dis. 2021; 13:1759720X21998279.
PMID: 33737966
PMC: 7934027.
DOI: 10.1177/1759720X21998279.
Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis.
Porta S, Otero-Losada M, Kolliker Frers R, Cosentino V, Kerzberg E, Capani F
Front Immunol. 2021; 11:590749.
PMID: 33643281
PMC: 7902722.
DOI: 10.3389/fimmu.2020.590749.
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis.
Chimenti M, DAntonio A, Conigliaro P, Ferrigno S, Vendola A, Ferraioli M
Biologics. 2020; 14:53-75.
PMID: 32903867
PMC: 7445514.
DOI: 10.2147/BTT.S260754.
